Pricing Log in Create free account

AbbVie Inc. (ABBV) vs Merck & Co., Inc. (MRK)

AbbVie Inc. and Merck & Co., Inc. are both Drug Manufacturers General companies. AbbVie Inc. is the larger, with a market value of $509.5B against $362.5B — 1.4× the size. AbbVie Inc. trades at the lower P/E: 49.7× against 118×. AbbVie Inc. grew revenue faster over the last twelve months: 10.7% against 4.89%. AbbVie Inc. has the higher net margin (15.6% vs 3.64%) and the higher return on invested capital (20.2% vs 0.00%). Both pay a dividend; AbbVie Inc. yields more (2.40% vs 2.31%). Across the 22 metrics below, AbbVie Inc. leads on 12 and Merck & Co., Inc. on 10.

Valuation

Metric ABBV MRK Drug Manufacturers General median
P/E 49.70 117.54 26.57
P/S 7.74 5.39 3.49
P/B n/m 8.64 5.20
Price to free cash flow 27.07 22.59 21.34
EV/EBITDA 20.10 29.70 14.80
EV/Sales 8.80 6.04 4.09
Earnings yield 2.01% 0.85% 2.40%
Free cash flow yield 3.69% 4.43% 4.43%

Profitability

Metric ABBV MRK Drug Manufacturers General median
Gross margin 73.72% 71.75% 73.01%
Operating margin 32.16% 9.20% 18.34%
Net margin 15.61% 3.64% 7.31%
Free cash flow margin 28.59% 0.00% 18.52%
Return on equity (288.69%) 0.00% 5.80%
Return on assets 7.32% 0.00% 2.28%
Return on invested capital 20.23% 0.00% 6.26%

Growth

Metric ABBV MRK Drug Manufacturers General median
Revenue growth (TTM) 10.68% 4.89% 6.72%
EPS growth (last fiscal year) (1.26%) 8.01% 21.81%
Revenue growth, 5-year CAGR 5.95% 9.38% 4.75%
Net income growth, 5-year CAGR (1.94%) 20.90% 0.00%

Health

Metric ABBV MRK Drug Manufacturers General median
Debt to equity (17.83) 1.22 0.63
Current ratio 0.87 1.32 1.39
Net debt to EBITDA 2.59 1.15 1.15

Dividend

Metric ABBV MRK Drug Manufacturers General median
Dividend yield 2.40% 2.31% 2.31%
Payout ratio 1.19 3.49 0.59

Size

Metric ABBV MRK Drug Manufacturers General median
Market cap 509.50b 362.53b 131.21b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack